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Abstract
Background: The incidence of chronic obstructive pulmonary disease (COPD) and bronchial
asthma began increasing in early 1960s in the population of Yokkaichi-city (Mie Prefecture, Japan).
The cause of the disease was sulfur oxide air pollution, and it is known as Yokkaichi Asthma. The
pollution markedly decreased by the end of 1970s; no new cases have been reported since 1988.
This study aimed at examining the late effects of air pollution on the health of Yokkaichi Asthma
patients.
Methods: Mortality rate and life expectancy of patients, registered between 1965 and 1988, were
investigated from 1975 through 2000.
Results: Mortality rates for COPD and asthma in patients from Yokkaichi-city were significantly
higher than in the whole population of Mie Prefecture. For all ages (except for males between 80
and 84 years in 1985), the life expectancy of both males and females were significantly reduced in
patients from Yokkaichi-city as compared with the whole population of Mie Prefecture. The
potential gains in life expectancy excluding the mortality for respiratory diseases including COPD
and asthma were larger for all ages in patients from Yokkaichi-city.
Conclusion: Mortality and life expectancy were adversely affected in patients from Yokkaichi-city,
despite the fact that the air pollution problem has been already solved.
Background
YOKKAICHI is a city with the largest population among
cities and towns of Mie Prefecture, and it is located in the
center of Japan. This is an industrial city and faces Ise Bay
on the Pacific Ocean side of the Japanese archipelago.
During World War II, naval fuel factories were constructed
in the southern part of Yokkaichi Harbor, but were
destroyed by bombing before they began to operate. In
1957, a petroleum complex was built and began to oper-
ate around the remnant of this facility. The complex
included the largest heavy oil-fired power station and
refinery in Japan at that time. As this complex used crude
oil with a high sulfur content (more than 3%) and did not
employ suitable measures for desulfurization, the annual
sulfur dioxide (SO2) emission level exceeded 100,000
tons, which caused air pollution with an increased con-
centration of sulfur oxides, as high as 1 ppm in the pol-
luted areas.
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By early 1960s, the incidence of respiratory diseases,
including bronchial asthma, increased among people liv-
ing in the vicinity of the complex, and this subsequently
became a major health problem in Japan, that was known
as Yokkaichi Asthma(Yokkaichi Zensoku, in Japanese). A
series of counter measures based on an area-wide total
emission control system were taken since 1972, as a result
of a successful lawsuit brought by nine inhabitants of the
area against six companies in the Yokkaichi Court, for rep-
arations of health damage caused by air pollution. Sulfur
oxide air pollution in this region has been markedly
reduced and the pollution reached the same level as that
in un-polluted areas by the end of 1970s; atmospheric sul-
fur oxide level is now below 0.01 ppm in the Yokkaichi
area [1]. Recently, a historical review of Yokkaichi pollu-
tion problem has been published [2].
Many investigators of Mie University [2-12] published a
bulk of reports regarding health problems among resi-
dents of Yokkaichi-city up to 1990. These studies revealed
that worsening of air pollution was associated with
increased mortality by bronchial asthma and chronic
bronchitis, and that the mortality due to bronchial
asthma decreased immediately after improvement of pol-
lution whereas the mortality by chronic bronchitis
decreased to the levels of control areas 4 to 5 years after
the concentration of SO2 was reduced to ambient air
standard. Similar trends were also observed in medical
consultation rates, incidence and prevalence of respiratory
diseases. For example, using British Medical Research
Council questionnaires, Yoshida et al [12] examined
inhabitants over 40 years of age in six districts of Yokkai-
chi-city and reported that 5–10% of the population living
in the polluted areas suffered from chronic bronchitis and
obstructive diseases whereas less than 3% suffered from
the same diseases in un-polluted areas. Also, Imai et al [8]
observed that, during the period of 1963–82, the mortal-
ity due to chronic bronchitis was 0.82, 4.60, and 57.72 per
100,000 population between ages of 40–49, 50–59, and
60-years, respectively, in polluted areas of Yokkaichi-city,
whereas it was 2.22, 1.51, and 33.82, respectively, in un-
polluted areas.
To offer financial support to the patients, a Public Relief-
System for air pollution was established in 1965 by the
Yokkaichi-city for the first time in the world. The system
was financed by the city; but in the next year, the Japanese
government decided that the national treasury, Mie Pre-
fecture and industries linked to the pollution must also
finance the public relief. In 1969, this program was
nationally expanded leading to the "Pollution-Related
Health Damage Special Measures Law" declared by the
Japanese government. Four years after, the "Pollution-
Related Health Damage Compensation Law" was enacted
and enforced.
The laws established that financial support to victims of
environmental pollution in Japan, including Yokkaichi
Asthma patients, is based on the imposition to industries,
which are responsible for the pollution. Thus, medical
expenses of patients from Yokkaichi-city who met the
three criterions below had been paid by the program:
1) With specific diseases: Diseases (bronchial asthma,
chronic bronchitis, pulmonary emphysema, and their
complication) that occur excessively in the polluted areas
and that have been confirmed epidemiologically.
2) In specific areas: Areas where prevalence of the specific
diseases has increased.
3) During specific period: Three years of residence in the
specific area.
Diagnosis of diseases was made based on clinical signs
and symptoms and laboratory findings such as chest X-
ray, arterial blood oxygen tension and lung function in
each hospital/clinic that the patients attended. Registra-
tion and compensation were carried out since 1965; no
new cases had been reported after 1988 in Yokkaichi.
It has been frequently documented that, as a traditional
pollutants, both SO2 and suspended particulate (SP) usu-
ally occur together, representing a complex mixture pro-
duced by fossil fuel (especially coal) consumption [13-
20]. Evidence has also shown that SP may exert adverse
effects on health without high level of SO2 [16,18,20].
However, residual health effects after the improvement of
pollution have not been well investigated.
The present study aimed at examining the late health
effects of air pollution that occurred several decades ago in
Yokkaichi. First, recent trends in mortality from respira-
tory diseases (i.e. chronic bronchitis, pulmonary emphy-
sema and asthma) among registered patients were
investigated. Also, life expectancy of the patients was
assessed, because this is one approach to assess health
effects of air pollution [21-23].
Methods
Subjects
Records of 1,354 patients registered in Yokkaichi-city dur-
ing 1965–1988 by "Public Relief-System by Yokkaichi-city
(1965)," "Pollution-Related Health Damage Special
Measures Law (1969)," and "Pollution-Related Health
Damage Compensation Law (1973)" were used in this
study with the authorization of the Yokkaichi-city public
office. Data obtained were sex, year of birth, the dates of
registration and death, cause of death, and diagnosis at
registration (Tables 1). Records of 1,232 patients [survival
518 (243 males and 275 females), death 714 (410 malesEnvironmental Health 2008, 7:8 http://www.ehjournal.net/content/7/1/8
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and 304 females, on December 30, 2002)] registered after
1973 were used for the analysis and to compare with the
whole population of Mie Prefecture, where the mortality
data are available since 1973 [24,25].
The population of Yokkaichi-city was 218,981(male
105,468; female 113,513), 247,001 (male 120,893;
female 126,108), 263,001(male 127,876; female
135,125) and 274,180 (male 134,161; female 140,019),
in 1965, 1975, 1985 and 1990, respectively. The popula-
tion of Mie Prefecture was 1,514,467 (male 727,802;
female 786,665), 1,626,002 (male 787,280; female
838,722), 1,747,311 (male 847,420; female 899,891)
and 179,2514 (male 869,515; female 922,999), in 1965,
1975, 1985 and 1990, respectively [25].
Age-adjusted mortality rate (indirect method)
Age-adjusted mortality rates of patients for all and specific
causes were calculated by the indirect method [26] using
age-specific mortality rates of the whole population of
Mie prefecture (standard population) in the census years
of 1975–2000 (every 5th year). In this calculation, the
number of patients in each age-group was the average over
± 2 years of the census year. Chronic bronchitis and pul-
monary emphysema were included in the group with
chronic obstructive pulmonary disease (COPD) by ICD10
[27], and the comparison between patients from Yokkai-
chi and the whole Mie Prefecture was performed in groups
with COPD and asthma, respectively.
Calculation of life expectancy by life-table method
The abridged life table method [28-31] was used to calcu-
late the life expectancy of patients with ages of 0–84 years
(5-year intervals). The fraction of the last age interval of
life [28] was used to construct an abridged life table.
Those fractions were calculated from a complete life table
in the Japan census years of 1975–2000 (every 5th year)
[32]. The number of patients was calculated on October 1
of each year; the number of death was the average over ±
2 years of the census year. Standard error (SE) for life
expectancy was estimated by Chiang method [28-
31,33,34]. By the same method, the life expectancy of the
whole population of Mie prefecture was calculated based
on data of Mie Prefecture [25] registered in the same
period.
Potential gains in life expectancy
Techniques for partial multiple decremental life tables
[29,35] were used to calculate the corresponding life
expectancies of patients from Yokkaichi and from the
whole population of Mie Prefecture by excluding the
death due to respiratory diseases such as chronic bronchi-
tis, pulmonary emphysema, asthma, pneumonia and
acute bronchitis. The gain in life expectancy was calcu-
Table 1: Number of deatha and survivalb among Yokkaichi Asthma patients
Sex 1975 1980 1985 1990 1995 2000
Deaths
Respiratory Diseases
Chronic bronchitis Males 4 10 6 5 2 5
F e m a l e s 148282
Pulmonary emphysema Males 4 2 0 3 1 2
F e m a l e s 001300
Asthma Males 6 15 10 20 6 6
F e m a l e s 798 1 057
Respiratory Cancer Males 0 3 5 3 3 4
F e m a l e s 010201
Othersc Males 5 9 18 12 11 6
F e m a l e s 71 1 1547
Other than respiratory Males 44 52 39 39 27 23
d i s e a s e s F e m a l e s 2 62 63 23 63 23 8
Total Males 63 91 82 82 50 46
F e m a l e s 4 14 15 85 84 95 5
Survivals Males 396 439 389 389 327 281
Females 369 417 422 422 372 317
aSum over 5 years (± 2 years of each year)
bOn October 1.
cRespiratory diseases other than the above-mentioned disorders.Environmental Health 2008, 7:8 http://www.ehjournal.net/content/7/1/8
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lated as the difference between the life expectancies with
and without these causes of death.
Results
For all causes, mortality rates were significantly higher in
patients from Yokkaichi than in the general population of
Mie Prefecture, excepting males in 1975 and females in
1980 (Fig 1). Mortality rates for COPD and asthma in
patients from Yokkaichi (116.29 and 105.11 per 100,000
in average for males and females, respectively) were
approximately 10- to 20-fold higher than in the general
population of Mie Prefecture (12.95 and 4.92 per 100,000
in average for males and females, respectively). Similarly,
the mortality for asthma in the Yokkaichi patients (178.0
and 179.0 in average for males and females, respectively)
was more than 20-folds higher than in the general popu-
lation of Mie Prefecture (7.26 and 4.46 in average for
males and females, respectively). By contrast, the mortal-
ity rates for all other causes were not significantly different
between the two groups.
The life expectancy for Yokkaichi patients and Mie Prefec-
ture is shown in Fig 2. For all ages (except for males of 80–
84 years in 1985), the life expectancy of both males and
females was significantly reduced in Yokkaichi patients as
compared with the whole population of Mie Prefecture,
for 1975–2000. The average difference in males of each
age group was 2.72, 8.50, 7.88, 6.95, 1.92 and 2.80 years
in 1975–2000, respectively; and in females, the difference
was 4.52, 5.27, 8.54, 5.31, 6.81 and 5.26 years, respec-
tively. As shown in Fig 3, difference in life expectancy was
larger in younger patients; differences among age-groups
became smaller during the observation period. The whole
life table is given as an Appendix (see Additional file 1).
The potential gain in life expectancy for Yokkaichi
patients and for the population of Mie Prefecture after
excluding mortality for respiratory diseases (see above) is
shown in Table 2. Yokkaichi patients showed greater gains
as compared with those from Mie Prefecture, i.e. 2.33–
3.32 and 1.51–4.19 years on average, for males and
females, respectively. The gain was less than 0.65 year for
the general population of Mie Prefecture in all age groups.
Discussion
The mortality rate for COPD and asthma in Yokkaichi
patients was significantly higher than in the whole popu-
lation of Mie Prefecture for 1975–2000. However, no sig-
nificant differences were observed among other illnesses.
Yokkaichi patients also showed shorter life expectancy
than the whole population of Mie Prefecture. As life
expectancy was calculated based on the death rate, it
appears that shortening of life expectancy reflects high
mortality rates in patients from Yokkaichi.
This observation agrees with the fact that potential gain in
life expectancy is more greatly prolonged in patients from
Yokkaichi than in the general population of Mie Prefec-
ture when death for respiratory diseases was excluded in
both males and females. The excess in gains of Yokkaichi
patients reached approximately half of the difference in
life expectancy between Yokkaichi patients and Mie Pre-
fecture (Table 2 and Fig 3), suggesting that decrease in life
expectancy was greatly due to respiratory mortality. Thus,
the present study revealed that delayed adverse health
effects still persisted among victims despite reduction in
air pollution and no further incidence of COPD and
asthma since 1988.
Several groups reported reduced life expectancy among
people living in air-polluted areas. Decrease of 1.51 year
was reported in Dutch men [21], 1.34–1.69 years in
Shanghai [22], and 2.5–3.1 years in US population [36].
Patients from Kurashiki-city, Japan, that suffered from res-
piratory diseases due to air pollution, have reported life
expectancy of 5.1 and 7.3 years (males and females)
shorter than the general Japanese population [23]. Loss of
life expectancy has been also reported in smokers. i.e. 3.5
and 2.2 years in 40 years old men and women in the Jap-
anese [34] and 8.6 years in the US population [36]. The
changes in life expectancy among subjects aged 40 or less
found in the present study seem much greater than these
observations, up to 1990. If the pollution in Yokkaichi-
city was not reduced by the end of 1970s, more magnitude
of adverse health effects could have been observed among
the victims. Although it has been argued that COPD mod-
els lack good data on life expectancy [37], estimation of
life expectancy and its potential gains after excluding spe-
cific causes appear to be useful for assessing the effects of
air pollution on health.
The studies on Yokkaichi Asthma had focused mainly on
the effects of SO2and/or sulfuric acid mists [2,8,38]
whereas those in other countries have shown that SO2 +
SP or SP alone lead to adverse health effects [13-20]. How-
ever, monthly prevalence of respiratory disease during the
period from 1962–65 was significantly correlated with the
corresponding values of SO2as well as with the amount of
dust fall in the Yokkaichi area, although the level of total
SP and dust fall in this area were reported to be low [3,8].
It had been suspected that low pH value of dust contrib-
uted to Yokkaichi Asthma problems [8,38].
It has been demonstrated that SO2 causes increased cardi-
ovascular mortality [17,19,39] and hospital admission
rate [19,40,41]. By contrast, no increased cardiovascular
mortality has been observed in residents of Yokkaichi[11]
where elevated mortality for COPD and asthma has been
reported [2-12]. Increase in cardiovascular mortality has
not been demonstrated in the registered patients ofEnvironmental Health 2008, 7:8 http://www.ehjournal.net/content/7/1/8
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Age-adjusted mortality rates in Yokkaichi Asthma patients and in the whole population of Mie Prefecture Figure 1
Age-adjusted mortality rates in Yokkaichi Asthma patients and in the whole population of Mie Prefecture. Per 100,000 popula-
tion. Closed = patients, open = Mie Prefecture. COPD = chronic bronchitis and pulmonary emphysema. *p < 0.05.
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Life expectancy for Yokkaichi Asthma patients and whole population of Mie Prefecture Figure 2
Life expectancy for Yokkaichi Asthma patients and whole population of Mie Prefecture. Average with standard error of mean 
(SEM). SEM was less than 0.04–0.19 years for Mie Prefecture. Closed = patients, open = Mie Prefecture. Significantly different 
(p < 0.05) between Yokkaichi patients and Mie population for all age subgroups except for males aged 80–84 years in 1985 (t-
test).
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Differences in life expectancy (years) between Yokkaichi patients and Mie Prefecture Figure 3
Differences in life expectancy (years) between Yokkaichi patients and Mie Prefecture. Blanks = unable to calculate because of 
no deaths.
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Yokkaichi Asthma [4,9,10]. The reason for this discrep-
ancy remains to be elucidated.
In the present study, there could have had an error in the
estimates of life expectancies by the Chiang method when
the population size is smaller than 1000 [42]. Because of
the small size of subjects, the statistical analysis should
have been done by Kaplan-Meier method for comparing
the survival curves between the patients and healthy peo-
ple during the same period, but these are not available.
The most important risk factor of COPD in the developed
world is cigarette smoking [43,44]. Other risk factors are
occupational or environmental exposure to dust, gas,
vapor or fumes [45], malnutrition [46] and increased air-
way responsiveness [47]. Further, asthmatics are sensitive
to air pollutants such as SO2, SP, ozone and nitrogen diox-
ide [48]. The effects of these risk factors on the patients
should be evaluated in future studies. Since prognosis of
COPD can be predicted by lung function such as FEV1
[49,50], analysis using lung function should be carried
Table 2: Potential gains in life expectancy(years) after excluding mortality for respiratory diseasesa
1975 1980 1985 1990 1995 2000
Ages(years) Patients Mie Patients Mie Patients Mie Patients Mie Patients Mie Patients Mie
Males
0–4 - 0.50 - 0.50 - 0.52 - 0.59 - 0.64 - 0.62
5–9 - 0.49 - 0.45 - 0.51 - 0.57 - 0.63 - 0.60
10–14 - 0.48 - 0.45 - 0.51 - 0.57 - 0.63 - 0.60
15–19 - 0.46 - 0.44 - 0.50 - 0.57 - 0.63 - 0.60
20–24 - 0.46 - 0.44 - 0.50 - 0.57 3.54 0.62 - 0.60
25–29 - 0.46 - 0.44 - 0.49 - 0.56 - 0.62 - 0.60
30–34 - 0.46 2.89 0.44 - 0.49 - 0.55 - 0.61 - 0.60
35–39 - 0.45 3.77 0.44 - 0.48 - 0.55 - 0.60 - 0.59
40–44 3.18 0.45 - 0.44 - 0.48 - 0.55 - 0.60 - 0.59
45–49 3.30 0.45 - 0.43 4.30 0.48 - 0.55 - 0.60 - 0.59
50–54 3.47 0.45 4.05 0.43 4.46 0.48 5.19 0.55 - 0.59 - 0.60
55–59 3.94 0.45 4.31 0.43 4.78 0.48 4.68 0.55 3.70 0.59 - 0.59
60–64 1.94 0.44 3.85 0.43 4.50 0.47 4.50 0.54 3.13 0.59 - 0.59
65–69 2.17 0.41 3.23 0.41 3.82 0.47 3.38 0.53 3.21 0.57 2.99 0.57
70–74 1.45 0.36 2.83 0.37 2.67 0.43 3.23 0.49 3.22 0.52 2.73 0.54
75–79 1.08 0.25 1.72 0.29 1.46 0.34 1.39 0.41 2.53 0.42 2.84 0.44
80–84 0.46 0.11 0.77 0.13 0.60 0.16 0.89 0.19 0.93 0.21 0.91 0.23
Average 2.33 0.42 3.05 0.41 3.32 0.46 3.32 0.52 2.90 0.57 2.37 0.56
Females
0–4 - 0.36 - 0.33 - 0.32 - 0.34 - 0.34 - 0.32
5–9 - 0.32 - 0.30 - 0.31 - 0.32 - 0.34 - 0.31
10–14 - 0.31 - 0.30 - 0.30 - 0.32 - 0.34 - 0.31
15–19 - 0.31 - 0.30 - 0.30 - 0.32 - 0.34 - 0.31
20–24 - 0.31 - 0.30 - 0.30 - 0.31 - 0.34 - 0.31
25–29 - 0.30 2.20 0.29 - 0.29 - 0.30 - 0.34 - 0.31
30–34 - 0.30 - 0.29 13.52 0.29 - 0.30 - 0.33 - 0.31
35–39 - 0.30 - 0.29 - 0.29 - 0.30 - 0.33 - 0.30
40–44 - 0.30 - 0.28 5.53 0.29 - 0.29 - 0.33 - 0.30
45–49 4.57 0.29 - 0.28 - 0.28 2.92 0.29 - 0.32 - 0.30
50–54 4.14 0.28 2.72 0.28 3.14 0.28 - 0.28 3.25 0.32 - 0.30
55–59 3.48 0.27 - 0.28 3.30 0.28 2.03 0.28 1.94 0.31 - 0.29
60–64 3.85 0.26 2.79 0.27 3.45 0.27 2.08 0.27 2.07 0.31 2.22 0.28
65–69 2.67 0.25 2.12 0.25 3.22 0.25 2.21 0.26 2.12 0.30 2.46 0.27
70–74 2.45 0.22 1.74 0.23 2.29 0.23 1.82 0.23 2.18 0.27 1.43 0.25
75–79 1.97 0.17 1.74 0.17 2.09 0.18 1.86 0.19 2.12 0.22 1.12 0.20
80–84 0.97 0.09 0.70 0.09 1.16 0.09 0.94 0.09 1.03 0.11 0.30 0.11
Average 3.01 0.27 2.00 0.27 4.19 0.27 1.98 0.28 2.10 0.30 1.51 0.28
aSee Methods section.
- = Unable to be calculated because of no deaths.Environmental Health 2008, 7:8 http://www.ehjournal.net/content/7/1/8
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out in Yokkaichi Asthma patients. Adequate measures for
health protection are also important to investigate.
Conclusion
Mortality and life expectancy were adversely affected in
the Yokkaichi Asthma patients due to increase in death for
respiratory diseases despite the fact that the problem of air
pollution has been already solved.
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